Catalyst
Slingshot members are tracking this event:
PDUFA Date of August 24th for Valeant's (VRX) Latanoprostene Bunod Ophthalmic Solution for Lowering Intraocular Pressure (IOP) in Patients with Open Angle Glaucoma or Ocular Hypertension
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| VRX |
|
|
COX.PA |
|
|
Bausch + Lomb |
|
|
Slingshot Insights Explained
Catalyst Date
Occurred on:
Aug 07, 2017
Occurred Source:
http://ir.valeant.com/news-releases/2017/08-07-2017-211747407
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Pdufa Date, Latanoprost Ophthalmic Solution, Eye Drop, Single Agent, Lowering Intraocular Pressure, Iop, Open Angle Glaucoma, Ocular Hypertension
